| Code | CSB-RA572514A0HU |
| Size | US$210 |
| Order now | |
| Image |
|
| Have Questions? | Leave a Message or Start an on-line Chat |
| Application | Recommended Dilution |
|---|---|
| WB | 1:500-1:2000 |
| FC | 1:50-1:200 |
PRKAA1, also known as AMPK alpha 1, serves as the catalytic subunit of AMP-activated protein kinase, a master regulator of cellular energy homeostasis. This kinase functions as a critical metabolic sensor, responding to changes in cellular AMP:ATP ratios to coordinate metabolic pathways including fatty acid oxidation, glucose uptake, and autophagy. Its central role in energy metabolism makes PRKAA1 a key target in research spanning metabolic disorders, cancer biology, and cardiovascular disease.
This recombinant monoclonal antibody, clone 6H8, offers researchers the reproducibility advantages inherent to recombinant technology. Because the antibody sequence is defined and produced from a stable expression system, you can expect consistent performance across experiments and between lots, eliminating the variability that can complicate long-term studies or multi-site collaborations.
Validation data demonstrates reliable detection of PRKAA1 across diverse human cell lines in Western blot applications, including HeLa, PC-3, Hep-G2, SW620, and U937 lysates. The antibody detects a band at the predicted molecular weight of 64 kDa, confirming target specificity. For Western blot experiments, dilutions between 1:500 and 1:2000 provide optimal results. Flow cytometry validation in Jurkat cells shows clear separation between specific staining and isotype control, with recommended dilutions of 1:50 to 1:200 for intracellular detection of this cytoplasmic kinase.
Whether investigating AMPK signaling in cancer metabolism, exploring its role in autophagy regulation, or studying metabolic adaptation in various disease models, this antibody provides a dependable tool for characterizing PRKAA1 expression and pathway activity in human samples.
There are currently no reviews for this product.